Axonics Modulation Technologies (AXNX) - Net Sales Margin

Axonics, Inc. (AXNX) operates within a narrow niche of bladder stimulators, integrating into a large medtech holding. The GURU.Markets platform reports effective sales margins, where the indicator value stands at -449.90. High profitability is driven by premium pricing. The company's dominance is secured by durable rechargeable implants that last over 15 years, minimizing the need for repeat surgeries.
Financial and market metric breakdowns for Axonics, Inc. (AXNX)

Axonics, Inc. (AXNX) implements high-tech, durable implants that require significant R&D investments. This indicator measures the share of net profit in revenue after covering all operating expenses. Investors track this ratio to identify hidden cost-of-sales pressure on capital. Analyzing adjusted net profit margins allows for the timely detection of declining business efficiency. The trend in adjusted net profit margins determines the fair value of the asset.